Serotypes and clonal diversity of streptococcus pneumoniae causing invasive disease in the Era of PCV13 in Catalonia, Spain

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Del Amo, Eva ^a   Esteva, Cristina ^a   Hernandez Bou, Susanna ^b   Galles, Carmen ^c   Navarro, Marian ^d   Sauca, Goretti ^e   Diaz, Alvaro ^f   Gassiot, Paula ^g   Marti, Carmina ^h   Larrosa, Nieves ⁱ   Ciruela, Pilar ^j   Jane, Mireia ^j   Sá Leão, Raquel ^k   Muñoz Almagro, Carmen ^a  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Hospital Sant Jaume de Calella   (Spain)

^d HOSPITAL GENERAL DE VIC   (Spain)

^e Hospital de Mata   (Spain)

^f Hospital de Nens   (Spain)

^g HOSPITAL DE FIGUERES   (Spain)

^h HOSPITAL GENERAL DE GRANOLLERS   (Spain)

ⁱ HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^j AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^k INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; 13-VALENT PNEUMOCOCCAL VACCINE; ANTIINFECTIVE AGENT;

ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLONAL VARIATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PNEUMOCOCCAL INFECTION; SEROTYPE; SPAIN; STREPTOCOCCUS PNEUMONIAE; ADOLESCENT; ADULT; AGED; CHILD; CLASSIFICATION; DRUG EFFECTS; FEMALE; GENETIC VARIATION; GENETICS; HUMAN; IMMUNOLOGY; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PRESCHOOL CHILD; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC VARIATION; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROGROUP; SPAIN; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 84962251937     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0151125     Document Type: Article

References (46)

1. Bogaert D, De Groot R, Hermans PW (2004) Streptococcus pneumoniae colonisation: The key to pneumococcal disease. Lancet Infect Dis. 4: 144-154. PMID: 14998500.
2. World Health Organization (2007) Pneumococcal conjugate vaccine for childhood immunization-WHO position paper. Relevé épidémiologique hebdomadaire/Section d'hygiène du Secrétariat de la Société des Nations. Weekly epidemiological record/Health Section of the Secretariat of the League of Nations. 82: 93-104.
3. Munoz-Almagro C, Bautista C, Arias MT, Boixeda R, Del Amo E, Borrás C, et al. (2014) High prevalence of genetically-determined mannose binding lectin deficiency in young children with invasive pneumococcal disease. Clin Microbiol Infect. 20(10):O745-O52. doi: 10.1111/1469-0691.12615 PMID: 24602163.
4. Geno KA, Gilbert GL, Song JY, Skovsted IC, Klugman KP, Jones C, et al. (2015) Pneumococcal capsules and their types: past, present and future. Clin Microbiol Rev. 28(3):871-99. doi: 10.1128/CMR.00024-15 PMID: 26085553.
5. Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, et al. (2010) Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 201(1):32-41. doi: 10.1086/648593 PMID: 19947881.
6. von Gottberg A, de Gouveja L, Tempia S, Quan V, Meiring S, von Mollendorf C, et al. (2014) Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med. 371(20):1889-1899. doi: 10.1056/NEJMoa1401914 PMID: 25386897.
7. Ben-Shimol S, Greenberg D, Givon-Lavi N, Elias N, Glikman D, Rubinstein U, et al. (2012) Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel. Vaccine. 30(46):6600-6607. doi: 10.1016/j.vaccine.2012.08.012 PMID: 22939907.
8. Miller E, Andrews NJ, Waight PA, Slack MP and George RC (2011) Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: An observational cohort study. Lancet Infect Dis. 11(10):760-768. doi: 10.1016/S1473-3099(11)70090-1 PMID: 21621466.
9. Dinleyici EC, Yargic ZA (2008) Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era. Expert Rev Vaccines. 7(9):1367-1394. doi: 10.1586/14760584.7.9.1367 PMID: 18980540.
10. Muñoz-Almagro C, Jordan I, Gene A, Latorre C, Garcia-Garcia JJ, Pallares R (2008) Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis. 46(2): 174-82 doi: 10.1086/524660 PMID: 18171247.
11. Moraga-Llop F, Garcia-Garcia JJ, Díaz-Conradi A, Ciruela P, Martínez J, González S, et al. (2015) VacVaccine failures in patients properly vaccinated with 13-valent pneumococcal conjugate vaccine in Catalonia, a region with low vaccination coverage. Pediatr Infect Dis J.
12. Browall S, Norman M, Tangrot J, Galanis I, Sjöström K, Dagerhamn J, et al. (2014) Intraclonal variations among Streptococcus pneumoniae isolates influence the likelihood of invasive disease in children. J Infect Dis. 209: 377-388. doi: 10.1093/infdis/jit481 PMID: 24009156.
13. Sandgren A, Sjöström K, Olsson-Liljequist B, Christensson B, Samuelsson A, Kronvall G, et al. (2004) Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. 189:785-796. PMID: 14976594.
14. Sjöström K, Spindler C, Ortqvist A, Kalin M, Sandgren A, Kühlmann-Berenzon S, et al. (2006) Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen. Clin Infect Dis. 42:451-9. PMID: 16421787.
15. Servei Català de la Salut. Informe del registre del conjunt mínim basic de dades (CMBD).
16. European public assessment report (EPAR), 2013. Prevenar 13: EPAR-Summary for the public. Available: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001104/human-med-001220.jsp&mid=WC0b01ac058001d124.
17. Anon, Manual de vacunas en línea de la AEP. Comité Asesor de Vacunas. Availablehttp://vacunasaep.org/documentos/manual/manual-de-vacunas. Accessed 2014 Jun 8.
18. European Committee on Antimicrobial Susceptibility Testing. 2013. Clinical breakpoints. Available: http://www.eucast.org/clinical-breakpoints/.
19. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. (2012) Multidrugresistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 18: 268-281. doi: 10.1111/j.1469-0691.2011.03570.x PMID: 21793988.
20. Selva L, del Amo E, Brotons P, Munoz-Almagro C (2012) Rapid and easy identification of capsular serotypes of Streptococcus pneumoniae by use of fragment analysis by automated fluorescencebased capillary electrophoresis. J Clin Microbiol. 50: 3451-3457. doi: 10.1128/JCM.01368-12 PMID: 22875895.
21. Austrian R (1976) The quellung reaction, a neglected microbiologic technique. Mt Sinai J Med. 43: 699-709. PMID: 13297.
22. Enright MC, Spratt BG (1998) A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology. 144 (Pt 11):3049-60. PMID: 9846740.
23. Feil EJ, Li BC, Aanensen DM, Hanage WP, Spratt BG (2004) eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol. 186: 1518-1530. PMID: 14973027.
24. Regev-Yochay G, Paran Y, Bishara J, Oren I, Chowers M, Tziba Y, et al. (2015) Early impact of PCV7/PCV13 sequential introduction to the national pediatric immunization plan, on adult invasive pneumococcal disease: A nationwide surveillance study. Vaccine. 33: 1135-1142. doi: 10.1016/j.vaccine.2015.01.030 PMID: 25613717.
25. Lepoutre A, Varon E, Georges S, Dorléans F, Janoir C, Gutmann L, et al. (2015) Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012. Vaccine. 33: 359-366. doi: 10.1016/j.vaccine.2014.11.011 PMID: 25448105.
26. Garcia Gabarrot G, López Vega M, Pérez Giffoni G, Hernández S, Cardinal P, Félix V, et al. (2014) Effect of pneumococcal conjugate vaccination in Uruguay, a middle-income country. PLoS One. 9: E112337. doi: 10.1371/journal.pone.0112337 PMID: 25375647.
27. Moore MR, Link-Gelles R, Schaffner W, Lynfield R, Lexau C, Bennett NM, et al. (2015) Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: Analysis of multisite, population-based surveillance. Lancet Infect Dis. 15: 301- 309. doi: 10.1016/S1473-3099(14)71081-3 PMID: 25656600.
28. van der Linden M, Falkenhorst G, Perniciaro S, Imöhl M (2015) Effects of infant pneumococcal conjugate vaccination on serotype distribution in invasive pneumococcal disease among children and adults in Germany. PLoS One. 10(7): E0131494. doi: 10.1371/journal.pone.0131494 PMID: 26132078.
29. Muñoz-Almagro C, Ciruela P, Esteva C, Marco F, Navarro M, Bartolome R, et al. (2011) Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain. J Infect. 63(2): 151-62. doi: 10.1016/j.jinf.2011.06.002 PMID: 21679725.
30. Antonio M, Dada-Adegbola H, Biney E, Awine T, O'Callaghan J, Pfluger V, et al. (2008) Molecular epidemiology of pneumococci obtained from Gambian children aged 2-29 months with invasive pneumococcaldisease during a trial of a 9-valent pneumococcal conjugate vaccine. BMC Infect Dis. 8: 81. doi: 10.1186/1471-2334-8-81 PMID: 18547404.
31. Setchanova LP, Alexandrova A, Dacheva D, Mitov I, Kaneva R, Mitev V (2015) Dominance of multidrug- resistant Denmark(14)-32 (ST230) clone among Streptococcus pneumoniae serotype 19A isolates causing pneumococcal disease in Bulgaria from 1992 to 2013. Microb Drug Resist. 21(1):35-42. doi: 10.1089/mdr.2014.0076 PMID: 25080213.
32. Aguiar SI, Pinto FR, Nunes S, Serrano I, Melo-Cristino J, Sá-Leão R, et al. (2010) Denmark14-230 clone as an increasing cause of pneumococcal infection in Portugal within a background of diverse serotype 19A lineages. J Clin Microbiol. 48(1):101-8. doi: 10.1128/JCM.00665-09 PMID: 19864476.
33. Ardanuy C, Tubau F, Pallares R, Calatayud L, Dominguez MA, Rolo D, et al. (2009) Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. Clin Infect Dis. 48(1):57-64. doi: 10.1086/594125PMID: 19035779.
34. Ardanuy C, Rolo D, Fenoll A, Tarrago D, Calatayud L, Liñares J (2009) Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain. J Antimicrob Chemother. 64 (3):507-510. doi: 10.1093/jac/dkp210 PMID: 19535383.
35. Selva L, Ciruela P, Blanchette K, del Amo E, Pallares R, Orihuela CJ, et al. (2012) Prevalence and clonal distribution of pcpA, psrP and Pilus-1 among pediatric isolates of Streptococcus pneumoniae. PLoS One. 7: E41587. doi: 10.1371/journal.pone.0041587 PMID: 22848535.
36. Barocchi MA, Ries J, Zogaj X, Hemsley C, Albiger B, Kanth A, et al. (2006) A pneumococcal pilus influences virulence and host inflammatory responses. Proc Natl Acad Sci U S A. 103: 2857-2862. PMID: 16481624.
37. Sjöström K, Blomberg C, Fernebro J, Dagerhamn J, Morfeldt E, Barocchi MA, et al. (2007) Clonal success of piliated penicillin nonsusceptible pneumococci. Proc Natl Acad Sci U S A. 104: 12907-12912. PMID: 17644611.
38. Del Amo E, Brotons P, Monsonis M, TriviñoM, Iñigo M, Selva L, et al. (2013) High invasiveness of pneumococcal serotypes included in the new generation of conjugate vaccines. Clin Microbiol Infect. 20(7):684-9. doi: 10.1111/1469-0691.12422 PMID: 24467648.
39. Del Amo E, Selva L, de Sevilla MF, Ciruela P, Brotons P, Triviño M, et al. (2015) Estimation of the invasive disease potential of Streptococcus pneumoniae in children by the use of direct capsular typing inclinical specimens. Eur J Clin Microbiol Infect Dis. 34(4):705-11. doi: 10.1007/s10096-014-2280-y PMID: 25413925.
40. Selva L, Ciruela P, Esteva C, de Sevilla MF, Codina G, Hernandez S, et al. (2012) Serotype 3 is a common serotype causing invasive pneumococcal disease in children less than 5 years old, as identified by real-time PCR. Eur J Clin Microbiol Infect Dis. 31(7):1487-95. doi: 10.1007/s10096-011-1468-7 PMID: 22052607.
41. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG (2003) Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- And clone-specific differences in invasive disease potential. J Infect Dis. 187: 1424-1432. PMID: 12717624.
42. Jefferies JM, Smith A, Clarke SC, Dowson C, Mitchell TJ (2004) Genetic analysis of diverse diseasecausing pneumococci indicates high levels of diversity within serotypes and capsule switching. J Clin Microbiol. 42: 5681-5688. PMID: 15583299.
43. Jauneikaite E, Carnon Jefferies JM, Vere Churton NW, Pin Lin RT, Hibberd ML, Clarke SC (2014) Genetic diversity of Streptococcus pneumoniae causing meningitis and sepsis in Singapore during the first year of PCV7 implementation. Emerg Microbes Infect 3.
44. Louie M, Louie L, Papia G, Talbot J, Lovgren, Simor AE (1999) Molecular analysis of the genetic variation among penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae serotypes in Canada. J Infect Dis. 179: 892-900. PMID: 10068584.
45. Overweg K, Bogaert D, Sluijter M, Yother J, Dankert J, de Groot R, et al. (2000) Genetic relatedness within serotypes of penicillin-susceptible Streptococcus pneumoniae isolates. J Clin Microbiol. 38 (12):4548-4553. PMID: 11101594.
46. Metcalf BJ, Gertz RE Jr, Gladstone RA, Walker H, Sherwood LK, Jackson D, et al. (2015) Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA. Clin Microbiol Infect. pii: S1198-743X(15)00813-7.